TAPI Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

TAPI (Technology & API Services) has announced the appointment of Serge Rogasik as Chief Executive Officer, leading TAPI as it enters its next chapter of growth and competitiveness.

Mr. Rogasik brings more than 25 years of global leadership experience across specialty ingredients, active ingredients, specialty chemicals and life sciences, with extensive experience building, scaling and repositioning businesses in highly regulated markets.

“I am honored to join TAPI at such an important moment in its evolution,” said Mr. Rogasik. “TAPI combines a unique set of capabilities, assets and talented people with a well-earned reputation as a trusted partner to customers worldwide. […] I am excited by the momentum in the business and see significant opportunities ahead to further strengthen TAPI’s position as a leading integrated API and CDMO partner.”

TAPI is one of the world’s largest producers of active pharmaceutical ingredients and a leading CDMO partner, with more than 4,000 employees, 13 manufacturing sites and six R&D facilities, supplying more than 350 active ingredients to customers around the world.

Mr. Rogasik and the TAPI team will be at CPHI Milan, October 6–8, 2026, in Hall 3, Booth A73, where customers and partners are invited to meet him and the teams behind TAPI’s catalog and CDMO businesses.

Read the full press release here